FDA SHOULD ALLOW POST-MARKETING SURVEY DATA IN LABELING, LILLY PREGNANCY GROUP SAYS; LILLY HAS PREGNANCY REGISTRIES FOR FOUR PRODUCTS, INCLUDING PROZAC

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet